Recall Record

Dublin, OH, United States

Cardinal Health Inc. recalls

16 recalls recorded since 2018, most recently on 5 August 2025. 10 are listed as ongoing. Status and classification are as published by the FDA.

Recalls16
Ongoing (FDA)10
Terminated or completed6
Class I (FDA)3

Ongoing Class II Drugs

Recall started
5 August 2025
Reason
Correct Labeled Product Mispack: Bags labeled for Enoxaparin Sodium Injection, 80 mg/0.8 mL, contained Enoxaparin Sodium Injection, 30 mg/0.3 mL
Distribution
KS
Initiated
Voluntary: Firm initiated
Recall number
D-0597-2025

Ongoing Class II Drugs

Recall started
30 July 2025
Reason
CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
Distribution
Nationwide Within the U.S.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0573-2025, D-0572-2025, D-0571-2025

Ongoing Class II Drugs

Recall started
9 April 2025
Reason
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Distribution
NC, SC, VA
Initiated
Voluntary: Firm initiated
Recall number
D-0393-2025

Ongoing Class I Drugs

Recall started
31 October 2023
Reason
Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0135-2024, D-0131-2024, D-0134-2024, D-0132-2024, D-0136-2024, D-0133-2024

Ongoing Class II Medical devices

Recall started
1 November 2022
Reason
Occlusion (blockage) of the bubble inlet port of the urinary drainage bag which may prevent urine draining into the bag. If the bladder is not emptied within a clinically appropriate time, this may increase the risk of urinary retention
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0356-2023, Z-0358-2023, Z-0360-2023, Z-0359-2023, Z-0361-2023, Z-0357-2023

Completed Class I, Class II Drugs

Recall started
5 April 2022
Reason
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions
Distribution
NM only
Initiated
Voluntary: Firm initiated
Recall numbers
D-0884-2022, D-0882-2022, D-0883-2022

Ongoing Class II Medical devices

Recall started
2 November 2021
Reason
Potential for open packaging seals compromising the sterility of the surgical gowns
Distribution
Worldwide distribution - US Nationwide and the countries of Chile, Thailand, Canada, Israel, LATAM Dist.Qatar, LATAM/Panama, LATAM/Mexico, LATAM/Colombia, LATAM/Costa Rica.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0376-2022, Z-0375-2022, Z-0371-2022, Z-0370-2022, Z-0372-2022, Z-0369-2022, Z-0377-2022, Z-0374-2022, Z-0368-2022, Z-0373-2022, Z-0378-2022

Ongoing Class I Medical devices

Recall started
4 August 2021
Reason
Potential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe.
Distribution
US Nationwide Distribution:  AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV and WY.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2286-2021, Z-2285-2021, Z-2284-2021

Ongoing Class II Medical devices

Recall started
16 March 2021
Reason
Due to shipping delays the devices were exposed to temperature excursions of 31.9¿F, intermittently over a 2 hour and 15 minute period of time which may cause inaccurate results.
Distribution
US Nationwide distribution in the states of FL, GA, SC.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1941-2021, Z-1942-2021, Z-1931-2021, Z-1930-2021, Z-1934-2021, Z-1936-2021, Z-1935-2021, Z-1939-2021, Z-1933-2021, Z-1938-2021, Z-1932-2021, Z-1929-2021 and 2 more

Terminated Class II Drugs

Recall started
15 March 2021
Terminated
17 June 2024
Reason
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Distribution
FL, GA, SC
Initiated
Voluntary: Firm initiated
Recall numbers
D-0429-2021, D-0435-2021, D-0448-2021, D-0503-2021, D-0401-2021, D-0451-2021, D-0484-2021, D-0467-2021, D-0471-2021, D-0424-2021, D-0529-2021, D-0414-2021 and 186 more

Terminated Class III Drugs

Recall started
9 March 2021
Terminated
4 November 2021
Reason
Temperature Abuse
Distribution
AL, LA, MS, TN
Initiated
Voluntary: Firm initiated
Recall number
D-0314-2021

Terminated Class II Medical devices

Recall started
20 April 2020
Terminated
23 July 2020
Reason
Three products requiring refrigerated storage conditions were incorrectly stored outside of approved temperature ranges. Using these temperature abused products may result in misdiagnosis of the patient.
Distribution
US Nationwide distribution NC, KS, and AL.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2050-2020, Z-2049-2020, Z-2051-2020

Terminated Class II Medical devices

Recall started
11 January 2020
Terminated
19 January 2023
Reason
The gowns contain an unknown level of bioburden, unknown microbiological flora, and unknown particulate contamination.
Distribution
Worldwide distribution US Nationwide including Puerto Rico and Guam, United Arab Emirates, Australia, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Israel, Mexico, Oman, Panama, Philippines, and Saudi Arabia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1016-2020, Z-1020-2020, Z-1012-2020, Z-1025-2020, Z-1037-2020, Z-1030-2020, Z-1008-2020, Z-1014-2020, Z-1024-2020, Z-1033-2020, Z-1022-2020, Z-1005-2020 and 27 more

Ongoing Class II Medical devices

Recall started
26 December 2019
Reason
The feeding spike sets may leak at the interface of the tube and spike connector.
Distribution
Worldwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2102-2020, Z-2105-2020, Z-2103-2020, Z-2100-2020, Z-2101-2020, Z-2104-2020

Ongoing Class II Medical devices

Recall started
14 November 2019
Reason
Cordis has initiated a labeling correction for S.M.A.R.T. and PRECISE stents due to incorrect MRI information on the IFU. The correct classification is "MRI Conditional" not "MRI Safe".
Distribution
Worldwide distribution - US Nationwide including Puerto Rico and countries of Algeria, Argentina, Armenia, Australia, Austria, Azerbaiian, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Czech Repulic, Denmark, Dominican Republic, Ecua
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0729-2020, Z-0728-2020, Z-0730-2020

Terminated Class II Medical devices

Recall started
16 November 2018
Terminated
4 November 2019
Reason
The double wrapping of this custom kit basin set is not supported by the current sterility assurance validation.
Distribution
US state of Florida
Initiated
Voluntary: Firm initiated
Recall number
Z-0702-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.